Capital Insight Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,834	Closed	-$200K	–	163
2025 Q1	$200K	Buy	+2,834	New	+$200K	0.04%	157
2024 Q3	–	Sell	-2,450	Closed	-$202K	–	159
2024 Q2	$202K	Buy	2,450 +60	+3%	+$4.94K	0.04%	156
2024 Q1	$209K	Buy	+2,390	New	+$209K	0.04%	160